Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Diabetes Mellitus: HELP
Hans Juergen Woerle
Based on 111 articles published since 2007
||||
Expertise Level
The expertise of Hans Juergen Woerle ranks in the
  • Top 0.0091%
  • ... of 275,240 published authors worldwide on Diabetes Mellitus
  • ... from 2007 through 2018
  • ... based on contributions to 111 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
World Expert badge
similar to this:
 
Aliases Woerle, Hans-Jürgen   ·   Woerle, Hans-Juergen   ·   Woerle, Hans J   ·   Woerle, H-J   ·   Woerle, H J   ·   Woerle, Hans Juergen
Work Locations
Details
Most likely:    Miscellaneous cities in Germany      
2017
  • 1 Profil GmbH , Neuss, Germany . · 2 Division of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz , Graz, Austria . · 3 Boehringer Ingelheim Pharma GmbH & Co. KG , Biberach, Germany . · 4 Boehringer Ingelheim Canada Ltd./Ltee , Burlington, Canada . · 5 Boehringer Ingelheim Pharma GmbH & Co. KG , Ingelheim, Germany . · Pubmed 27929674
  • Department of Internal Medicine I, University Hospital Aachen, RWTH Aachen University, Aachen, Germany · Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX. · The George Institute for Global Health, University of Sydney, Sydney, Australia. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Dallas Diabetes Research Center at Medical City, Dallas, TX. · Pubmed 28830955
  • Institute of Clinical Pharmacology, Hannover Medical School, Hannover, Germany; Institute for Aerospace Medicine, German Aerospace Center (DLR), Cologne, Germany. Electronic address: · Institute of Clinical Pharmacology, Hannover Medical School, Hannover, Germany; Institute for Aerospace Medicine, German Aerospace Center (DLR), Cologne, Germany. · Institute of Clinical Pharmacology, Hannover Medical School, Hannover, Germany. · Profil, Neuss, Germany. · Renal Division, University of Würzburg, Würzburg, Germany. · Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Pubmed 28757109
  • Department of Diabetes, Endocrinology and Nutrition, Instituto de Investigación Biomédica de Málaga (IBIMA) Hospital Universitario Virgen de la Victoria, Universidad Málaga, Málaga, Spain. · CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Málaga, Spain. · Department of Medicine IV (Endocrinology, Diabetes, Angiology, Nephrology & Clinical Chemistry), Eberhard Karls University, Tübingen, Germany. · Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Pubmed 27762093
2016
  • Centre Hospitalier Universitaire Poitiers and INSERM CIC 1402, Poitiers, France · Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX. · Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Pubmed 27493136
  • Toronto General Hospital, 585 University Ave, 8N-845, Toronto, ON, Canada, M5G 2N2. · Department of Medicine, Division of Nephrology, and Department of Physiology, University of Toronto, Toronto, ON, Canada. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada. · Abdominal Centre Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland. · Folkhälsan Research Centre, Biomedicum Helsinki, Helsinki, Finland. · Baker IDI Heart and Diabetes Institute, Melbourne, VIC, Australia. · Pubmed 27316632
  • Seoul St. Mary's Hospital, The Catholic University of Korea School of Medicine, Seoul, Korea. · Jikei University School of Medicine, Tokyo, Japan. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut, USA. · Pubmed 27265507
  • Diabetes Centre Bad Lauterberg, Bad Lauterberg im Harz, Germany Division of Diabetology, Medical Department I, St. Josef-Hospital (Ruhr-University Bochum), Bochum, Germany · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Boehringer Ingelheim Ltd, Bracknell, UK. · Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA. · Pubmed 27190087
  • Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Profil, Neuss, Germany. · Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany. · Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA. · Pubmed 26799632
  • Department of Clinical and Experimental Medicine, University of Pisa, Via Roma, 67, 56100, Pisa, Italy. · C.N.R. Institute of Neuroscience, Padua, Italy. · Profil, Neuss, Germany. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Department of Clinical and Experimental Medicine, University of Pisa, Via Roma, 67, 56100, Pisa, Italy. · CNR Institute of Clinical Physiology, Pisa, Italy. · Pubmed 26704626
  • Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada; University of Toronto, Toronto, Ontario, Canada. Electronic address: · Department of Clinical Sciences, Lund University, Lund, Sweden. · Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany. · Boehringer Ingelheim Ltd, Bracknell, United Kingdom. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Boehringer Ingelheim Norway KS, Asker, Norway. · Pubmed 26474870
  • Profil, Neuss, Germany. Electronic address: · Institute of Clinical Pharmacology, Hannover Medical School, Hannover, Germany. · Renal Division, University of Würzburg, Würzburg, Germany. · Profil, Neuss, Germany. · Merck & Co. Inc., Kenilworth, New Jersey, USA. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Pubmed 27692976
  • a LMC Endocrinology Centres , University of Calgary , Calgary , Canada. · b Joslin Diabetes Center , Harvard Medical School , Boston , MA , USA. · c Department of Endocrinology and Metabolism, Section of Diabetes , University of Pisa , Pisa , Italy. · d Department of Medicine IV , Universitätsklinikum Tübingen , Tübingen , Germany. · e Boehringer Ingelheim Pharmaceuticals Inc , Ridgefield , CT , USA. · f Boehringer Ingelheim Ltd , Bracknell , UK. · g Boehringer Ingelheim Pharma GmbH & Co. KG , Ingelheim , Germany. · Pubmed 27684308
  • Profil, Neuss, Germany. Electronic address: · Institute of Clinical Pharmacology, Hannover Medical School, Hannover, Germany. · Renal Division, University of Würzburg, Würzburg, Germany. · Profil, Neuss, Germany. · Merck & Co., Inc. Kenilworth, New Jersey, USA. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Pubmed 27666126
  • Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut, USA. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Boehringer Ingelheim Pharma GmbH, Biberach, Germany. · Pubmed 27376831
  • Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany. Electronic address: · Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, Connecticut. · Boehringer Ingelheim Pharma GmbH, Biberach an der Riss, Germany. · Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany. · Pubmed 27085585
  • Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA · Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, TX, USA. · University of Texas Health Science Center at San Antonio, San Antonio, TX, USA. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Germany. · Boehringer Ingelheim Norway KS, Asker, Norway. · Pubmed 26873905
  • Valme University Hospital Medical School, Seville, Spain. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Department of Medicine, University of Helsinki, Helsinki, Finland. · Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX, USA. · Boehringer Ingelheim Ltd, Bracknell, UK. · Pubmed 26605991
2015
  • Yale-New Haven Hospital, Yale University School of Medicine, New Haven, CT, USA. · Division of Diabetology, St. Josef Hospital, Ruhr-University Bochum, Bochum, Germany. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Center for Metabolic Research, Veterans Affairs San Diego Healthcare System, University of California San Diego School of Medicine, San Diego, CA, USA. · Pubmed 25974030
  • Section of Endocrinology, Yale School of Medicine, New Haven, CT, USA. · Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada. · Division of Nephrology, University of Würzburg, Würzburg, Germany. · Department of Cardiology and LTTA Centre, University Hospital of Ferrara, Ferrara, Italy Maria Cecilia Hospital, GVM Care & Research, E.S: Health Science Foundation, Cotignola, Italy. · St Michael's Hospital, University of Toronto, Toronto, ON, Canada. · Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany. · Boehringer Ingelheim España S.A, Barcelona, Spain. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Boehringer Ingelheim Norway K.S, Asker, Norway · Pubmed 25589482
  • Department of Endocrinology and Diabetology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany. · Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research, Düsseldorf, Germany. · German Center for Diabetes Research, Partner Düsseldorf, Düsseldorf, Germany. · Diabetes- und Nierenzentrum, Dormagen, Germany. · Boehringer Ingelheim Danmark A/S, Copenhagen, Denmark. · Boehringer Ingelheim France S.A.S., Reims, France. · Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Pubmed 26701110
  • Department of Medicine, University of Texas Health Science Center, San Antonio, TX, USA. · Helsinki University Hospital and Minerva Institute for Medical Research, University of Helsinki, Helsinki, Finland. · Department of Cardiology, Harvard Clinical Research Institute, Boston, MA, USA. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Boehringer Ingelheim Norway KS, Asker, Norway. · Pubmed 26343814
  • Department of Internal Medicine IV, University of Tübingen, Otfried-Muller-Str. 10, 72076 Tübingen, Germany. Electronic address: · Diabetes- und Nierenzentrum, Dormagen, Elsa-Brändström-Str. 17, D-41540 Dormagen, Germany. Electronic address: · Boehringer Ingelheim Danmark A/S, Strødamvej 52, 2100 København, Denmark. · Boehringer Ingelheim Reims S.A.S., 12 Rue André Huet, 51100 Reims, France. Electronic address: · Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, CT 06788, USA. Electronic address: · Boehringer Ingelheim Pharma GmbH & Co. KG, Binger Str. 173, 55216 Ingelheim, Germany. Electronic address: · Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88397 Biberach, Germany. Electronic address: · Boehringer Ingelheim Pharma GmbH & Co. KG, Binger Str. 173, 55216 Ingelheim, Germany. Electronic address: · Boehringer Ingelheim Pharma GmbH & Co. KG, Binger Str. 173, 55216 Ingelheim, Germany. Electronic address: · Pubmed 26324220
  • Health Sciences Centre, Memorial University, St. John's, Newfoundland, Canada. Electronic address: · Diabetes Care and Research Institute, Chennai, India. · Diabetes- und Nierenzentrum, Dormagen, Germany. · Boehringer Ingelheim Danmark A/S Strødamvej 52, Copenhagen, Denmark. · Boehringer Ingelheim France S.A.S, Reims, France. · Boehringer Ingelheim GmbH & Co. KG, Ingelheim, Germany. · Pubmed 26138864
  • Division of Endocrinology and Metabolism, Department of Internal Medicine, Medical University of Graz, Graz, Austria. · Profil, Neuss, Germany. · Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany. · Boehringer Ingelheim France, Reims, France. · Boehringer Ingelheim Canada Ltd./Ltee, Burlington, Canada. · Boehringer Ingelheim Norway K.S, Asker, Norway. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Pubmed 26080652
  • Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX, USA. · Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA. · Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Pubmed 26040302
  • Diabetes- und Nierenzentrum, Dormagen, Germany. · University of Tübingen, Tübingen, Germany. · Boehringer Ingelheim Danmark A/S, Copenhagen, Denmark. · Boehringer Ingelheim France S.A.S., Reims, France. · Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany. · Pubmed 26031566
  • Washington University School of Medicine in St Louis, St Louis, MO, USA · University of Helsinki, Helsinki, Finland. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Pubmed 25941160
  • Department of Metabolic Medicine, Kumamoto University, Kumamoto, Japan. · Division of Endocrinology, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi, Japan. · Nippon Boehringer Ingelheim Co., Ltd, Tokyo, Japan. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA. · Pubmed 25772548
  • National Research Institute, Los Angeles, CA. · University of Texas Health Science Center, San Antonio, TX · Boehringer Ingelheim Ltd., Bracknell, Berkshire, U.K. · Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Pubmed 25633662
  • University of Texas Health Science Center, San Antonio, TX · National Research Institute, Los Angeles, CA. · Boehringer Ingelheim, Ltd., Bracknell, Berkshire, U.K. · Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Pubmed 25583754
  • Department of Medicine, Helsinki University Central Hospital, and Minerva Institute for Medical Research, Helsinki, Finland · Boehringer Ingelheim Finland Ky, Helsinki, Finland. · Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany. · inVentiv Health Clinical, Maidenhead, U.K. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Pubmed 25271206
  • Department of Medicine, Division of Endocrinology and Metabolism, University of Toronto, Toronto, ON, Canada. · Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, Canada. · Department of Medicine, Division of Nephrology, Toronto General Hospital, University Health Network, University of Toronto, Toronto, ON, Canada. · Boehringer Ingelheim Canada Ltd./Ltée, Burlington, ON, Canada. · WHO Collaborating Center, Minneapolis, Minnesota, United States of America. · Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut, United States of America. · Boehringer Ingelheim Pharma GmbH & Co.KG, Ingelheim, Germany. · Boehringer Ingelheim Norway K.S, Asker, Norway. · Pubmed 26544192
  • Folkhälsan Institute of Genetics, Folkhälsan Research Center, Biomedicum Helsinki, Helsinki, Finland Division of Nephrology, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland Baker IDI Heart & Diabetes Institute, Melbourne, VIC, Australia · Baker IDI Heart & Diabetes Institute, Melbourne, VIC, Australia. · The George Institute for Global Health, University of Sydney, Sydney, NSW, Australia. · Research Service and Division of Nephrology-Hypertension, Veterans Affairs San Diego Healthcare System, Veterans Medical Research Foundation, San Diego, CA, USA Center for Renal Translational Medicine, Department of Medicine, University of California, San Diego, La Jolla, CA, USA. · Department of Internal Medicine, Rudolfstiftung Hospital, Vienna, Austria. · Division of Metabolism and Biosystemic Science, Department of Medicine, Asahikawa Medical University, Asahikawa, Japan. · Institute of Nutritional Science, University of Potsdam, Potsdam, Germany. · Boehringer Ingelheim, Reims, France. · Boehringer Ingelheim, Ingelheim, Germany. · Pubmed 26224765
  • Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX, USA. · Department of Internal Medicine I, University Hospital Aachen, Aachen, Germany. · Boehringer Ingelheim, Biberach, Germany. · Boehringer Ingelheim, Ingelheim, Germany. · Boehringer Ingelheim, Bracknell, Berkshire, UK. · Boehringer Ingelheim, Ingelheim, Germany. · Boehringer Ingelheim, Drengsrudbekken 8, 1373 Asker, Oslo, Norway. · Pubmed 25990013
  • Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia. Electronic address: · George Institute for Global Health, University of Sydney, New South Wales, Australia. · Washington University in St Louis, St Louis, MO. · Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia; Folkhälsan Institute of Genetics, Folkhälsan Research Center, Biomedicum Helsinki, Helsinki, Finland; Division of Nephrology, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland. · University of Würzburg, Würzburg, Germany. · Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX. · Boehringer Ingelheim, Ingelheim, Germany. · Pubmed 25960304
  • LMC Endocrinology Centres, Calgary, Alberta, Canada. · Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany. · Boehringer Ingelheim France S.A.S., Reims, France. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Pubmed 25827441
  • Department of Internal Medicine I, University Hospital Aachen, Aachen, Germany · Dallas Diabetes and Endocrine Center at Medical City and University of Texas, Southwestern Medical Center, Dallas, TX, USA. · Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, VA Puget Sound Health Care System and University of Washington, Seattle, WA, USA. · Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, Canada University of Toronto, Toronto, ON, Canada. · Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands. · The Biostatistics Center, The George Washington University, Rockville, MD, USA. · Department of Biostatistics, Wake Forest Baptist Medical Center, Winston-Salem, NC, USA. · Boehringer Ingelheim, Biberach, Germany. · Boehringer Ingelheim, Ingelheim, Germany. · Boehringer Ingelheim, Bruxelles, Belgium. · Boehringer Ingelheim, Bracknell, UK. · Boehringer Ingelheim, Asker, Norway. · Pubmed 25780262
  • Profil Institut für Stoffwechselforschung GmbH, Neuss, Germany. Electronic address: · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut, USA. · Pubmed 25636696
  • Department of Medicine, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland · Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX. · Department of Medicine, Division of Nephrology, Helsinki University Central Hospital, Helsinki, Finland; Folkhälsan Institute of Genetics, Folkhälsan Research Center, Biomedicum Helsinki, Helsinki, Finland; and Baker IDI Heart and Diabetes Institute, Melbourne, Australia. · Diabetes and Endocrinology Centre, Heart of England National Health Service Foundation Trust, and University of Birmingham, Birmingham, U.K. · Department of Medicine IV, Universitäts-Klinikum Tübingen, Tübingen, Germany. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Boehringer Ingelheim Ky, Helsinki, Finland. · Boehringer Ingelheim Ltd., Bracknell, U.K. · Pubmed 25614693
2014
  • Steno Diabetes Center, Gentofte, Denmark. Electronic address: · Boehringer Ingelheim Norway, Asker, Norway. · Boehringer Ingelheim Pharma, Biberach, Germany. · Boehringer Ingelheim Pharma, Ingelheim, Germany. · Pubmed 24948511
  • Diabetes Centre, Heart of England NHS Foundation Trust and University of Birmingham, Birmingham, UK. Electronic address: · Division of Endocrinology and Diabetes, Medanta Medicity Sector 38, Gurgaon, Delhi NCR, India. · Boehringer Ingelheim Ltd, Bracknell, Berkshire, UK. · Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany. · Pubmed 24795251
  • Diabetes America, Plano, Texas. Electronic address: · Diabetes Nation, Sisters, Oregon. · Boehringer Ingelheim, Pharma GmbH & Co KG, Ingelheim, Germany. · Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, Connecticut. · Pubmed 25236917
  • Nippon Boehringer Ingelheim Co Ltd, Hyogo, Japan. Electronic address: · Department of Molecular Sciences on Diabetes, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; Department of Molecular Diabetic Medicine, Diabetes Research Center, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan. · Nippon Boehringer Ingelheim Co Ltd, Hyogo, Japan. · Nippon Boehringer Ingelheim Co Ltd, Tokyo, Japan. · Boehringer Ingelheim GmbH & Co KG, Ingelheim, Germany. · Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, Connecticut. · Pubmed 25199997
  • Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX · Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT. · Boehringer Ingelheim France, Reims, France. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Pubmed 24929430
  • University of Tübingen, Tübingen, Germany · Diabetes-und Nierenzentrum, Dormagen, Germany. · Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Pubmed 24722494
  • Medical Investigations Inc., Little Rock, Arkansas. · Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut. · Boehringer Ingelheim Ltd., Bracknell, United Kingdom. · Boehringer Ingelheim GmbH and Co., KG, Ingelheim, Germany. · Pubmed 24326003
  • Diabetes Centre, Heart of England NHS Foundation Trust, and University of Birmingham, Birmingham, B9 5SS, UK. Electronic address: · Boehringer Ingelheim, Ingelheim, Germany. · Boehringer Ingelheim, Bracknell, UK. · Pubmed 24461123
2013
  • Clinics of Endocrinology and Diabetology, Heinrich-Heine University, Düsseldorf, Germany; German Diabetes Center, Institute for Clinical Diabetology, Düsseldorf, Germany. Electronic address: · Diabetes Institute of Guangdong Province, Key Lab of Diabetology of Guangdong Province, The Third Affiliated Hospital of Sun Yat-sen University, Canton, China. · Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany. · Boehringer Ingelheim France, Reims, France. · Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim am Rhein, Germany. · Pubmed 24622369
2014
  • Drug Metabolism and Pharmacokinetics, Development, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Straße 65, 88397, Biberach/Riss, Germany, · Pubmed 24906949
  • Profil Institut für Stoffwechselforschung GmbH, Neuss, Germany. · Pubmed 24821586
2013
  • Boehringer Ingelheim, Biberach, Germany. · Pubmed 23331248
  • Diabetes Center Mergentheim, Bad Mergentheim, Germany. · Pubmed 24118640
  • 1Department of Translational Medicine, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany; and Departments of 2Biostatics 3Therapeutic Area Metabolism, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Pubmed 23411609
  • Profil, Hellersbergstrasse 9, Neuss, Germany. · Pubmed 23356556
2012
  • Diabetes Center Mergentheim, Bad Mergentheim, Germany. · Pubmed 22356132
  • Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany Boehringer Ingelheim, Germany. · Pubmed 22242621
Probable:    Ludwig-Maximillians-Universitat      
2012
  • Department of Internal Medicine II, Clinical Research Unit, Clinical Center of the Ludwig Maximilians University, Campus Grosshadern, Munich, Germany. · Pubmed 22721966
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 111 total) written by Hans Juergen Woerle about Diabetes Mellitus:

  • Glucose Exposure and Variability with Empagliflozin as Adjunct to Insulin in Patients with Type 1 Diabetes: Continuous Glucose Monitoring Data from a 4-Week, Randomized, Placebo-Controlled Trial (EASE-1). 2017
  • Composite Primary End Points in Cardiovascular Outcomes Trials Involving Type 2 Diabetes Patients: Should Unstable Angina Be Included in the Primary End Point? 2017
  • The effect of empagliflozin on muscle sympathetic nerve activity in patients with type II diabetes mellitus. 2017
  • Empagliflozin and Cerebrovascular Events in Patients With Type 2 Diabetes Mellitus at High Cardiovascular Risk. 2017
  • Influence of common polymorphisms in the SLC5A2 gene on metabolic traits in subjects at increased risk of diabetes and on response to empagliflozin treatment in patients with diabetes. 2017
  • Empagliflozin and Cardiovascular Outcomes in Asian Patients With Type 2 Diabetes and Established Cardiovascular Disease - Results From EMPA-REG OUTCOME 2017
  • Linagliptin as add-on to empagliflozin and metformin in patients with type 2 diabetes: Two 24-week randomized, double-blind, double-dummy, parallel-group trials. 2017
  • Impact of Empagliflozin on Blood Pressure in Patients With Type 2 Diabetes Mellitus and Hypertension by Background Antihypertensive Medication. 2016
  • Initial Combination of Empagliflozin and Metformin in Patients With Type 2 Diabetes. 2016
  • The effect of sodium glucose cotransporter 2 inhibition with empagliflozin on microalbuminuria and macroalbuminuria in patients with type 2 diabetes. 2016
Show List of Full Article Records
Google Searches

Learn more about Hans Juergen Woerle using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Miscellaneous cities in Germany
Ludwig-Maximillians-Universitat
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Miscellaneous cities in Germany
2017
  • 1 Profil GmbH , Neuss, Germany . · 2 Division of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz , Graz, Austria . · 3 Boehringer Ingelheim Pharma GmbH & Co. KG , Biberach, Germany . · 4 Boehringer Ingelheim Canada Ltd./Ltee , Burlington, Canada . · 5 Boehringer Ingelheim Pharma GmbH & Co. KG , Ingelheim, Germany . · Pubmed 27929674
  • Department of Internal Medicine I, University Hospital Aachen, RWTH Aachen University, Aachen, Germany · Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX. · The George Institute for Global Health, University of Sydney, Sydney, Australia. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Dallas Diabetes Research Center at Medical City, Dallas, TX. · Pubmed 28830955
  • Institute of Clinical Pharmacology, Hannover Medical School, Hannover, Germany; Institute for Aerospace Medicine, German Aerospace Center (DLR), Cologne, Germany. Electronic address: · Institute of Clinical Pharmacology, Hannover Medical School, Hannover, Germany; Institute for Aerospace Medicine, German Aerospace Center (DLR), Cologne, Germany. · Institute of Clinical Pharmacology, Hannover Medical School, Hannover, Germany. · Profil, Neuss, Germany. · Renal Division, University of Würzburg, Würzburg, Germany. · Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Pubmed 28757109
  • Department of Diabetes, Endocrinology and Nutrition, Instituto de Investigación Biomédica de Málaga (IBIMA) Hospital Universitario Virgen de la Victoria, Universidad Málaga, Málaga, Spain. · CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Málaga, Spain. · Department of Medicine IV (Endocrinology, Diabetes, Angiology, Nephrology & Clinical Chemistry), Eberhard Karls University, Tübingen, Germany. · Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Pubmed 27762093
2016
  • Centre Hospitalier Universitaire Poitiers and INSERM CIC 1402, Poitiers, France · Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX. · Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Pubmed 27493136
  • Toronto General Hospital, 585 University Ave, 8N-845, Toronto, ON, Canada, M5G 2N2. · Department of Medicine, Division of Nephrology, and Department of Physiology, University of Toronto, Toronto, ON, Canada. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada. · Abdominal Centre Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland. · Folkhälsan Research Centre, Biomedicum Helsinki, Helsinki, Finland. · Baker IDI Heart and Diabetes Institute, Melbourne, VIC, Australia. · Pubmed 27316632
  • Seoul St. Mary's Hospital, The Catholic University of Korea School of Medicine, Seoul, Korea. · Jikei University School of Medicine, Tokyo, Japan. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut, USA. · Pubmed 27265507
  • Diabetes Centre Bad Lauterberg, Bad Lauterberg im Harz, Germany Division of Diabetology, Medical Department I, St. Josef-Hospital (Ruhr-University Bochum), Bochum, Germany · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Boehringer Ingelheim Ltd, Bracknell, UK. · Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA. · Pubmed 27190087
  • Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Profil, Neuss, Germany. · Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany. · Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA. · Pubmed 26799632
  • Department of Clinical and Experimental Medicine, University of Pisa, Via Roma, 67, 56100, Pisa, Italy. · C.N.R. Institute of Neuroscience, Padua, Italy. · Profil, Neuss, Germany. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Department of Clinical and Experimental Medicine, University of Pisa, Via Roma, 67, 56100, Pisa, Italy. · CNR Institute of Clinical Physiology, Pisa, Italy. · Pubmed 26704626
  • Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada; University of Toronto, Toronto, Ontario, Canada. Electronic address: · Department of Clinical Sciences, Lund University, Lund, Sweden. · Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany. · Boehringer Ingelheim Ltd, Bracknell, United Kingdom. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Boehringer Ingelheim Norway KS, Asker, Norway. · Pubmed 26474870
  • Profil, Neuss, Germany. Electronic address: · Institute of Clinical Pharmacology, Hannover Medical School, Hannover, Germany. · Renal Division, University of Würzburg, Würzburg, Germany. · Profil, Neuss, Germany. · Merck & Co. Inc., Kenilworth, New Jersey, USA. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Pubmed 27692976
  • a LMC Endocrinology Centres , University of Calgary , Calgary , Canada. · b Joslin Diabetes Center , Harvard Medical School , Boston , MA , USA. · c Department of Endocrinology and Metabolism, Section of Diabetes , University of Pisa , Pisa , Italy. · d Department of Medicine IV , Universitätsklinikum Tübingen , Tübingen , Germany. · e Boehringer Ingelheim Pharmaceuticals Inc , Ridgefield , CT , USA. · f Boehringer Ingelheim Ltd , Bracknell , UK. · g Boehringer Ingelheim Pharma GmbH & Co. KG , Ingelheim , Germany. · Pubmed 27684308
  • Profil, Neuss, Germany. Electronic address: · Institute of Clinical Pharmacology, Hannover Medical School, Hannover, Germany. · Renal Division, University of Würzburg, Würzburg, Germany. · Profil, Neuss, Germany. · Merck & Co., Inc. Kenilworth, New Jersey, USA. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Pubmed 27666126
  • Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut, USA. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Boehringer Ingelheim Pharma GmbH, Biberach, Germany. · Pubmed 27376831
  • Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany. Electronic address: · Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, Connecticut. · Boehringer Ingelheim Pharma GmbH, Biberach an der Riss, Germany. · Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany. · Pubmed 27085585
  • Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA · Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, TX, USA. · University of Texas Health Science Center at San Antonio, San Antonio, TX, USA. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Germany. · Boehringer Ingelheim Norway KS, Asker, Norway. · Pubmed 26873905
  • Valme University Hospital Medical School, Seville, Spain. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Department of Medicine, University of Helsinki, Helsinki, Finland. · Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX, USA. · Boehringer Ingelheim Ltd, Bracknell, UK. · Pubmed 26605991
2015
  • Yale-New Haven Hospital, Yale University School of Medicine, New Haven, CT, USA. · Division of Diabetology, St. Josef Hospital, Ruhr-University Bochum, Bochum, Germany. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Center for Metabolic Research, Veterans Affairs San Diego Healthcare System, University of California San Diego School of Medicine, San Diego, CA, USA. · Pubmed 25974030
  • Section of Endocrinology, Yale School of Medicine, New Haven, CT, USA. · Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada. · Division of Nephrology, University of Würzburg, Würzburg, Germany. · Department of Cardiology and LTTA Centre, University Hospital of Ferrara, Ferrara, Italy Maria Cecilia Hospital, GVM Care & Research, E.S: Health Science Foundation, Cotignola, Italy. · St Michael's Hospital, University of Toronto, Toronto, ON, Canada. · Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany. · Boehringer Ingelheim España S.A, Barcelona, Spain. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Boehringer Ingelheim Norway K.S, Asker, Norway · Pubmed 25589482
  • Department of Endocrinology and Diabetology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany. · Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research, Düsseldorf, Germany. · German Center for Diabetes Research, Partner Düsseldorf, Düsseldorf, Germany. · Diabetes- und Nierenzentrum, Dormagen, Germany. · Boehringer Ingelheim Danmark A/S, Copenhagen, Denmark. · Boehringer Ingelheim France S.A.S., Reims, France. · Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Pubmed 26701110
  • Department of Medicine, University of Texas Health Science Center, San Antonio, TX, USA. · Helsinki University Hospital and Minerva Institute for Medical Research, University of Helsinki, Helsinki, Finland. · Department of Cardiology, Harvard Clinical Research Institute, Boston, MA, USA. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Boehringer Ingelheim Norway KS, Asker, Norway. · Pubmed 26343814
  • Department of Internal Medicine IV, University of Tübingen, Otfried-Muller-Str. 10, 72076 Tübingen, Germany. Electronic address: · Diabetes- und Nierenzentrum, Dormagen, Elsa-Brändström-Str. 17, D-41540 Dormagen, Germany. Electronic address: · Boehringer Ingelheim Danmark A/S, Strødamvej 52, 2100 København, Denmark. · Boehringer Ingelheim Reims S.A.S., 12 Rue André Huet, 51100 Reims, France. Electronic address: · Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, CT 06788, USA. Electronic address: · Boehringer Ingelheim Pharma GmbH & Co. KG, Binger Str. 173, 55216 Ingelheim, Germany. Electronic address: · Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88397 Biberach, Germany. Electronic address: · Boehringer Ingelheim Pharma GmbH & Co. KG, Binger Str. 173, 55216 Ingelheim, Germany. Electronic address: · Boehringer Ingelheim Pharma GmbH & Co. KG, Binger Str. 173, 55216 Ingelheim, Germany. Electronic address: · Pubmed 26324220
  • Health Sciences Centre, Memorial University, St. John's, Newfoundland, Canada. Electronic address: · Diabetes Care and Research Institute, Chennai, India. · Diabetes- und Nierenzentrum, Dormagen, Germany. · Boehringer Ingelheim Danmark A/S Strødamvej 52, Copenhagen, Denmark. · Boehringer Ingelheim France S.A.S, Reims, France. · Boehringer Ingelheim GmbH & Co. KG, Ingelheim, Germany. · Pubmed 26138864
  • Division of Endocrinology and Metabolism, Department of Internal Medicine, Medical University of Graz, Graz, Austria. · Profil, Neuss, Germany. · Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany. · Boehringer Ingelheim France, Reims, France. · Boehringer Ingelheim Canada Ltd./Ltee, Burlington, Canada. · Boehringer Ingelheim Norway K.S, Asker, Norway. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Pubmed 26080652
  • Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX, USA. · Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA. · Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Pubmed 26040302
  • Diabetes- und Nierenzentrum, Dormagen, Germany. · University of Tübingen, Tübingen, Germany. · Boehringer Ingelheim Danmark A/S, Copenhagen, Denmark. · Boehringer Ingelheim France S.A.S., Reims, France. · Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany. · Pubmed 26031566
  • Washington University School of Medicine in St Louis, St Louis, MO, USA · University of Helsinki, Helsinki, Finland. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Pubmed 25941160
  • Department of Metabolic Medicine, Kumamoto University, Kumamoto, Japan. · Division of Endocrinology, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi, Japan. · Nippon Boehringer Ingelheim Co., Ltd, Tokyo, Japan. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA. · Pubmed 25772548
  • National Research Institute, Los Angeles, CA. · University of Texas Health Science Center, San Antonio, TX · Boehringer Ingelheim Ltd., Bracknell, Berkshire, U.K. · Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Pubmed 25633662
  • University of Texas Health Science Center, San Antonio, TX · National Research Institute, Los Angeles, CA. · Boehringer Ingelheim, Ltd., Bracknell, Berkshire, U.K. · Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Pubmed 25583754
  • Department of Medicine, Helsinki University Central Hospital, and Minerva Institute for Medical Research, Helsinki, Finland · Boehringer Ingelheim Finland Ky, Helsinki, Finland. · Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany. · inVentiv Health Clinical, Maidenhead, U.K. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Pubmed 25271206
  • Department of Medicine, Division of Endocrinology and Metabolism, University of Toronto, Toronto, ON, Canada. · Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, Canada. · Department of Medicine, Division of Nephrology, Toronto General Hospital, University Health Network, University of Toronto, Toronto, ON, Canada. · Boehringer Ingelheim Canada Ltd./Ltée, Burlington, ON, Canada. · WHO Collaborating Center, Minneapolis, Minnesota, United States of America. · Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut, United States of America. · Boehringer Ingelheim Pharma GmbH & Co.KG, Ingelheim, Germany. · Boehringer Ingelheim Norway K.S, Asker, Norway. · Pubmed 26544192
  • Folkhälsan Institute of Genetics, Folkhälsan Research Center, Biomedicum Helsinki, Helsinki, Finland Division of Nephrology, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland Baker IDI Heart & Diabetes Institute, Melbourne, VIC, Australia · Baker IDI Heart & Diabetes Institute, Melbourne, VIC, Australia. · The George Institute for Global Health, University of Sydney, Sydney, NSW, Australia. · Research Service and Division of Nephrology-Hypertension, Veterans Affairs San Diego Healthcare System, Veterans Medical Research Foundation, San Diego, CA, USA Center for Renal Translational Medicine, Department of Medicine, University of California, San Diego, La Jolla, CA, USA. · Department of Internal Medicine, Rudolfstiftung Hospital, Vienna, Austria. · Division of Metabolism and Biosystemic Science, Department of Medicine, Asahikawa Medical University, Asahikawa, Japan. · Institute of Nutritional Science, University of Potsdam, Potsdam, Germany. · Boehringer Ingelheim, Reims, France. · Boehringer Ingelheim, Ingelheim, Germany. · Pubmed 26224765
  • Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX, USA. · Department of Internal Medicine I, University Hospital Aachen, Aachen, Germany. · Boehringer Ingelheim, Biberach, Germany. · Boehringer Ingelheim, Ingelheim, Germany. · Boehringer Ingelheim, Bracknell, Berkshire, UK. · Boehringer Ingelheim, Ingelheim, Germany. · Boehringer Ingelheim, Drengsrudbekken 8, 1373 Asker, Oslo, Norway. · Pubmed 25990013
  • Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia. Electronic address: · George Institute for Global Health, University of Sydney, New South Wales, Australia. · Washington University in St Louis, St Louis, MO. · Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia; Folkhälsan Institute of Genetics, Folkhälsan Research Center, Biomedicum Helsinki, Helsinki, Finland; Division of Nephrology, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland. · University of Würzburg, Würzburg, Germany. · Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX. · Boehringer Ingelheim, Ingelheim, Germany. · Pubmed 25960304
  • LMC Endocrinology Centres, Calgary, Alberta, Canada. · Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany. · Boehringer Ingelheim France S.A.S., Reims, France. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Pubmed 25827441
  • Department of Internal Medicine I, University Hospital Aachen, Aachen, Germany · Dallas Diabetes and Endocrine Center at Medical City and University of Texas, Southwestern Medical Center, Dallas, TX, USA. · Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, VA Puget Sound Health Care System and University of Washington, Seattle, WA, USA. · Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, Canada University of Toronto, Toronto, ON, Canada. · Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands. · The Biostatistics Center, The George Washington University, Rockville, MD, USA. · Department of Biostatistics, Wake Forest Baptist Medical Center, Winston-Salem, NC, USA. · Boehringer Ingelheim, Biberach, Germany. · Boehringer Ingelheim, Ingelheim, Germany. · Boehringer Ingelheim, Bruxelles, Belgium. · Boehringer Ingelheim, Bracknell, UK. · Boehringer Ingelheim, Asker, Norway. · Pubmed 25780262
  • Profil Institut für Stoffwechselforschung GmbH, Neuss, Germany. Electronic address: · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut, USA. · Pubmed 25636696
  • Department of Medicine, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland · Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX. · Department of Medicine, Division of Nephrology, Helsinki University Central Hospital, Helsinki, Finland; Folkhälsan Institute of Genetics, Folkhälsan Research Center, Biomedicum Helsinki, Helsinki, Finland; and Baker IDI Heart and Diabetes Institute, Melbourne, Australia. · Diabetes and Endocrinology Centre, Heart of England National Health Service Foundation Trust, and University of Birmingham, Birmingham, U.K. · Department of Medicine IV, Universitäts-Klinikum Tübingen, Tübingen, Germany. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Boehringer Ingelheim Ky, Helsinki, Finland. · Boehringer Ingelheim Ltd., Bracknell, U.K. · Pubmed 25614693
2014
  • Steno Diabetes Center, Gentofte, Denmark. Electronic address: · Boehringer Ingelheim Norway, Asker, Norway. · Boehringer Ingelheim Pharma, Biberach, Germany. · Boehringer Ingelheim Pharma, Ingelheim, Germany. · Pubmed 24948511
  • Diabetes Centre, Heart of England NHS Foundation Trust and University of Birmingham, Birmingham, UK. Electronic address: · Division of Endocrinology and Diabetes, Medanta Medicity Sector 38, Gurgaon, Delhi NCR, India. · Boehringer Ingelheim Ltd, Bracknell, Berkshire, UK. · Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany. · Pubmed 24795251
  • Diabetes America, Plano, Texas. Electronic address: · Diabetes Nation, Sisters, Oregon. · Boehringer Ingelheim, Pharma GmbH & Co KG, Ingelheim, Germany. · Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, Connecticut. · Pubmed 25236917
  • Nippon Boehringer Ingelheim Co Ltd, Hyogo, Japan. Electronic address: · Department of Molecular Sciences on Diabetes, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; Department of Molecular Diabetic Medicine, Diabetes Research Center, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan. · Nippon Boehringer Ingelheim Co Ltd, Hyogo, Japan. · Nippon Boehringer Ingelheim Co Ltd, Tokyo, Japan. · Boehringer Ingelheim GmbH & Co KG, Ingelheim, Germany. · Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, Connecticut. · Pubmed 25199997
  • Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX · Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT. · Boehringer Ingelheim France, Reims, France. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Pubmed 24929430
  • University of Tübingen, Tübingen, Germany · Diabetes-und Nierenzentrum, Dormagen, Germany. · Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany. · Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Pubmed 24722494
  • Medical Investigations Inc., Little Rock, Arkansas. · Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut. · Boehringer Ingelheim Ltd., Bracknell, United Kingdom. · Boehringer Ingelheim GmbH and Co., KG, Ingelheim, Germany. · Pubmed 24326003
  • Diabetes Centre, Heart of England NHS Foundation Trust, and University of Birmingham, Birmingham, B9 5SS, UK. Electronic address: · Boehringer Ingelheim, Ingelheim, Germany. · Boehringer Ingelheim, Bracknell, UK. · Pubmed 24461123
2013
  • Clinics of Endocrinology and Diabetology, Heinrich-Heine University, Düsseldorf, Germany; German Diabetes Center, Institute for Clinical Diabetology, Düsseldorf, Germany. Electronic address: · Diabetes Institute of Guangdong Province, Key Lab of Diabetology of Guangdong Province, The Third Affiliated Hospital of Sun Yat-sen University, Canton, China. · Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany. · Boehringer Ingelheim France, Reims, France. · Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim am Rhein, Germany. · Pubmed 24622369
2014
  • Drug Metabolism and Pharmacokinetics, Development, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Straße 65, 88397, Biberach/Riss, Germany, · Pubmed 24906949
  • Profil Institut für Stoffwechselforschung GmbH, Neuss, Germany. · Pubmed 24821586
2013
  • Boehringer Ingelheim, Biberach, Germany. · Pubmed 23331248
  • Diabetes Center Mergentheim, Bad Mergentheim, Germany. · Pubmed 24118640
  • 1Department of Translational Medicine, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany; and Departments of 2Biostatics 3Therapeutic Area Metabolism, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. · Pubmed 23411609
  • Profil, Hellersbergstrasse 9, Neuss, Germany. · Pubmed 23356556
2012
  • Diabetes Center Mergentheim, Bad Mergentheim, Germany. · Pubmed 22356132
  • Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany Boehringer Ingelheim, Germany. · Pubmed 22242621
Ludwig-Maximillians-Universitat
2012
  • Department of Internal Medicine II, Clinical Research Unit, Clinical Center of the Ludwig Maximilians University, Campus Grosshadern, Munich, Germany. · Pubmed 22721966
39 Other Locations Show
Yearly article counts 07162926231000000
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.